Deutsche Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $273K | Buy |
|
|||||
|
2024
Q3 | $325K | Buy |
|
|||||
|
2024
Q2 | $95.2K | Sell |
|
|||||
|
2024
Q1 | $224K | Buy |
|
|||||
|
2023
Q4 | $389K | Sell |
|
|||||
|
2023
Q3 | $517K | Buy |
|
|||||
|
2023
Q2 | $1.01M | Sell |
|
|||||
|
2023
Q1 | $1.85M | Sell |
|
|||||
|
2022
Q4 | $2.92M | Buy |
|
|||||
|
2022
Q3 | $873K | Sell |
|
|||||
|
2022
Q2 | $566K | Sell |
|
|||||
|
2022
Q1 | $892K | Sell |
|
|||||
|
2021
Q4 | $827K | Buy |
|
|||||
|
2021
Q3 | $1.33M | Sell |
|
|||||
|
2021
Q2 | $1.86M | Sell |
|
|||||
|
2021
Q1 | $3.9M | Buy |
|
|||||
|
2020
Q4 | $1.42M | Buy |
|
|||||
|
2020
Q3 | $949K | Sell |
|
|||||
|
2020
Q2 | $3.29M | Sell |
|
|||||
|
2020
Q1 | $2.6M | Buy |
|
|||||
|
2019
Q4 | $2.53M | Buy |
|
|||||
|
2019
Q3 | $404K | Sell |
|
|||||
|
2019
Q2 | $6.55M | Buy |
|
|||||
|
2019
Q1 | $7.42M | Buy |
|
|||||
|
2018
Q4 | $6.68M | Buy |
|
|||||
|
2018
Q3 | $5.8M | Sell |
|
|||||
|
2018
Q2 | $8.17M | Buy |
|
|||||
|
2018
Q1 | $5.17M | Buy |
|
|||||
|
2017
Q4 | $4.59M | Buy |
|
|||||
|
2017
Q3 | $3.15M | Sell |
|
|||||
|
2017
Q2 | $3.09M | Buy |
|
|||||
|
2017
Q1 | $343K | Sell |
|
|||||
|
2016
Q4 | $494K | Buy |
|
|||||
|
2016
Q3 | $313K | Sell |
|
|||||
|
2016
Q2 | $300K | Buy |
|
|||||
|
2016
Q1 | $215K | Buy |
|
|||||
|
2015
Q4 | $190K | Sell |
|
|||||
|
2015
Q3 | $692K | Sell |
|
|||||
|
2015
Q2 | $2.48M | Buy |
|
|||||
|
2015
Q1 | $823K | Buy |
|
|||||
|
2014
Q4 | $125K | Sell |
|
|||||
|
2014
Q3 | $203K | Sell |
|
|||||
|
2014
Q2 | $464K | Buy |
|
|||||
|
2014
Q1 | $55K | Buy |
|